Global report - November 15, 2025
MSD to acquire Cidara Therapeutics for USD 9.2 billion
Merck (known as MSD outside of the United States and Canada), and Cidara Therapeutics, a biotech company developing drug-Fc conjugate (DFC) therapeutics, have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Cidara for a total transaction value of approximately USD 9.2 billion.
Global report - November 3, 2025
Pfizer files lawsuit against Metsera and Novo Nordisk for breach of merger agreement
Pfizer has filed a lawsuit against Metsera, its Board of Directors, and Novo Nordisk, in the Delaware Court of Chancery.
Acquisition - November 3, 2025
Thermo Fisher Scientific to acquire Clario
Thermo Fisher Scientific has announced a definitive agreement to acquire Clario Holdings, a provider of endpoint data solutions for clinical trials, from a shareholder group led by Astorg and Nordic Capital, Novo Holding and Cinven, for USD 8.875 billion in cash at close plus potential additional earnout and other payments in the future, largely dependent on performance.
Acquisition - October 27, 2025
Novartis to acquire RNA therapeutics company Avidity Biosciences
Novartis has entered into an agreement to acquire Avidity Biosciences, a San Diego-based, biopharmaceutical company focused on a new class of therapeutics enabling RNA delivery to muscle.
Global report - October 27, 2025
New platform to strengthen defence against future pandemics
The AI-powered Global Pathogen Analysis Platform aims to strengthen the pandemic preparedness globally.
Global report - October 26, 2025
Basel: Small in size – Large in life science
The northwestern corner of Switzerland offers a unique life science ecosystem, with a great mix of startups and global big pharma in close by.
